Roivant Sciences Ltd (ROIV) insider trading
Every open-market stock purchase and sale by Roivant Sciences Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Meghan Fitzgerald (Director) and 1 other sold $399K in the last 90 days.
- Last insider buy: Matthew Gline (CEO), $50K, 12 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $845M (39 sales). Last close $36.13 on Sep 24, 2026.
Recent ROIV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 20, 2026 | Richard Pulik (CFO) | Sold (not open market) | $84.7K |
| Sep 16, 2026 | Daniel Allen Gold (Director) | Bought (not open market) | — |
| Sep 16, 2026 | James C Momtazee (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Meghan Fitzgerald (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Daniel Allen Gold (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Melissa B Epperly (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Ilan Oren (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Ilan Oren (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Meghan Fitzgerald (Director) | Bought (not open market) | — |
| Sep 16, 2026 | James C Momtazee (Director) | Bought (not open market) | — |
| Sep 16, 2026 | Melissa B Epperly (Director) | Bought (not open market) | — |
| Sep 15, 2026 | Meghan Fitzgerald (Director) | Sold | $187K |
| Sep 15, 2026 | Melissa B Epperly (Director) | Sold | $172K |
| Sep 15, 2026 | Melissa B Epperly (Director) | Sold | $24.2K |
| Sep 15, 2026 | Meghan Fitzgerald (Director) | Sold | $16.2K |
| Sep 10, 2026 | James C Momtazee (Director) | Sold (not open market) | $119K |
| Sep 10, 2026 | Ilan Oren (Director) | Sold (not open market) | $97.4K |
| Sep 10, 2026 | Melissa B Epperly (Director) | Sold (not open market) | $89.2K |
| Sep 10, 2026 | Meghan Fitzgerald (Director) | Sold (not open market) | $71.4K |
| Jun 30, 2026 | Keith S Manchester (Insider) | Sold | $7.1M |
| Jun 30, 2026 | QVT Financial LP (Insider) | Sold | $437K |
| Jun 30, 2026 | Keith S Manchester (Insider) | Sold | $437K |
| Jun 30, 2026 | Daniel Allen Gold (Insider) | Sold | $437K |
| Jun 29, 2026 | Keith S Manchester (Insider) | Sold | $20.8M |
| Jun 29, 2026 | Daniel Allen Gold (Insider) | Sold | $20.8M |
Who's trading ROIV
- Richard Pulik, CFO: sold $9.1M (2 sales), last Sep 20, 2026
- Meghan Fitzgerald, Insider: sold $2.1M (3 sales), last Sep 16, 2026
- Daniel Allen Gold, Insider: sold $147M (19 sales), last Sep 16, 2026
- Melissa B Epperly, Insider: sold $1.4M (3 sales), last Sep 16, 2026
- James C Momtazee, Insider: other filings, last Sep 16, 2026
- Ilan Oren, Insider: other filings, last Sep 16, 2026
- Keith S Manchester, Insider: sold $154M (20 sales), last Jun 30, 2026
- QVT Financial LP, Insider: sold $147M (19 sales), last Jun 30, 2026
- Mayukh Sukhatme, C-suite exec: sold $72.6M (6 sales), last Jun 26, 2026
- Eric Venker, CEO: sold $75.6M (19 sales), last Jun 24, 2026
- Jennifer Humes, C-suite exec: sold $384K (1 sale), last Jun 20, 2026
- Matthew Gline, CEO: sold $46.2M (4 sales), last Apr 16, 2026
- Frank Torti, President: sold $82M (3 sales), last Mar 31, 2026
- Vivek Ramaswamy, 10% owner: sold $106M (6 sales), last Dec 15, 2025
Get free alerts when an insider at Roivant Sciences Ltd files a new trade →